Cyclosporine A as a Primary Treatment for Panniculitis-like T Cell Lymphoma: A Case with a Long-Term Remission

Subcutaneous panniculitis-like T cell lymphoma (SPTL) is a distinctive cutaneous lymphoma characterized by an infiltration of subcutaneous tissue by neoplastic T cells, similar to panniculitis. It is well-established that patients who are diagnosed with SPTL usually respond poorly to chemotherapy, showing fatal outcome. As a first line treatment for SPTL, anthracycline-based chemotherapy was most frequently used. For the treatment of SPTL, the efficacy of cyclosporine A has been recently reported in relapsed SPTL after anthracycline-based chemotherapy. However, it is still not clear whether cyclosporine A can be used as a first-line treatment against SPTL. Here, we report a case of SPTL, which achieved complete remission for nine years after first-line cyclosporine A therapy. This study suggests that cyclosporine A can induce a complete long-term remission as a first-line treatment.

[1]  V. Devita,et al.  DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology , 2015 .

[2]  M. Kang,et al.  Cyclosporine A treatment for relapsed subcutaneous panniculitis-like T-cell lymphoma: a case with long-term follow-up , 2012, The Korean journal of hematology.

[3]  H. Ryoo,et al.  Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation , 2011, Cancer research and treatment : official journal of Korean Cancer Association.

[4]  M. Taniwaki,et al.  Cyclosporine A for Chemotherapy-Resistant Subcutaneous Panniculitis-Like T Cell Lymphoma with Hemophagocytic Syndrome , 2011, Acta Haematologica.

[5]  Ying-min Liang,et al.  Treatment relapsed subcutaneous panniculitis-like T-cell lymphoma together HPS by Cyclosporin A , 2010, Hematology reports.

[6]  Z. Parveen,et al.  Subcutaneous panniculitis-like T-cell lymphoma: redefinition of diagnostic criteria in the recent World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas. , 2009, Archives of pathology & laboratory medicine.

[7]  C. Massone,et al.  Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. , 2008, Blood.

[8]  T. N. Nakorn,et al.  Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma , 2007, Leukemia & lymphoma.

[9]  Ahmad A. Al Robaee,et al.  Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporin A. , 2006, Skinmed.

[10]  Takeshi Inoue,et al.  Subcutaneous panniculitis-like T-cell lymphoma: successful initial treatment with prednisolone and cyclosporin A. , 2006, Internal medicine.

[11]  S. Wester,et al.  Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis‐like T‐cell lymphoma , 2004, Cancer.

[12]  A. Paller,et al.  Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy. , 2004, Journal of the American Academy of Dermatology.

[13]  N. Nguyen Subcutaneous T-cell lymphoma. , 2003, Dermatology online journal.

[14]  M. Paulli,et al.  Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma: report of 7 cases. , 2000, Archives of dermatology.

[15]  G. Steele Cancer: Principles and Practice of Oncology , 1983 .